Gynecologic Cancer News

A large study of drinking habits in the oncology population revealed high rates of alcohol consumption among patients with and survivors of cancer.

The NCI awarded a 5-year, $8.3 million research grant to Weill Cornell Medicine, Moffitt Cancer Center and Universidade de Sao Paulo in Brazil to investigate strategies to prevent HPV-related cancers among individuals with HIV.

One dose of the HPV vaccine appeared to be as effective as multiple doses in preventing preinvasive cervical disease among adolescents vaccinated between ages 15 and 19 years, according to results of a retrospective study published in Cancer.

High HPV vaccination coverage for girls and scaled-up screening and treatment may lead to the elimination of cervical cancer in most lower-middle-income countries over the next 100 years, according to results of two modeling studies published in The Lancet.

About 14,000 women each year die of ovarian cancer, making it one of the deadliest gynecologic cancers.

Cervical Cancer Awareness Month is observed every January.

The FDA granted priority review to olaparib in combination with bevacizumab as first-line maintenance treatment of women with advanced ovarian cancer, according to the agent’s manufacturer.

Cancer mortality rates dropped by 29% between 1991 and 2017 in the United States, with a 2.2% drop between 2016 and 2017, according to according to data from Cancer Statistics 2020, American Cancer Society’s annual report on cancer rates and trends.

Proton chemoradiotherapy appeared associated with a substantial reduction in acute adverse events that caused unplanned hospitalizations compared with traditional photon chemoradiotherapy among adults with locally advanced cancer, according to results of a retrospective study published in JAMA Oncology.

Researchers did not find a significantly higher risk for ovarian cancer in women who used powder in the genital area, according to an analysis of more than 250,000 women recently published in JAMA.